Fundraising Fox
Outcomes4Me
Cambridge, US · Founded 2017 · Delaware corporation · 34 employees on LinkedIn · 8 known investors
Find your way into Outcomes4Me
Sign up to see every warm intro you have to Outcomes4Me
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Outcomes4Me team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
Founders & leadership
Outcomes4Me was founded in 2017 by Maya R. Said, Osama Rahma, and Maya R. Said, Sc.D..
Board
Investors · 8
How we know: Asset Management Company's portfolio page · Not right? Tell us
How we know: HealthX Ventures's portfolio page · Not right? Tell us
How we know: Sierra Ventures's portfolio page · funding news · outcomes4me.com · Not right? Tell us
How we know: a partner's Signal profile · outcomes4me.com · Not right? Tell us
How we know: a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$37.5M disclosed across 3 of 4 rounds · 2020–2025
- $21MraisedMay 2025 · 3 sourcesSource ↗
▶$12MraisedApr 2021 · 7 investors · Other TechnologyRule 506(b)
- Andrea JacksonDirector
- David AucklandDirector
- Maya SaidExecutive Officer, Director
- David FleshmanDirector
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4.5MraisedJan 2020 · 6 investors · Other TechnologyRule 506(b)
- David AucklandDirector
- David FleshmanDirector
- Maya SaidExecutive Officer, Director
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Outcomes4Me.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $399.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Outcomes4Me do?
- Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
- Who founded Outcomes4Me?
- Outcomes4Me was founded by Maya R. Said, Osama Rahma, Maya R. Said, Sc.D. in 2017.
- Who are Outcomes4Me's investors?
- Outcomes4Me's investors include Asset Management Company, HealthX Ventures, Sierra Ventures, Asset Management Ventures, Northpond Ventures.
- How much funding has Outcomes4Me raised?
- Outcomes4Me has disclosed $37.5M raised across 3 of its 4 known rounds.
- Where is Outcomes4Me headquartered?
- Outcomes4Me is headquartered in Cambridge, US.